PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB)

Market Closed
8 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 94
-0.02
-0.4%
$
2.24M Market Cap
- P/E Ratio
0% Div Yield
4,330,575 Volume
- Eps
$ 4.96
Previous Close
Day Range
4.5 5.6
Year Range
4.29 99.96
Want to track ELAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ELAB closed today lower at $4.94, a decrease of 0.4% from yesterday's close, completing a monthly decrease of -6.79% or $0.36. Over the past 12 months, ELAB stock lost -70.84%.
ELAB is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
PMGC Holdings Inc. has completed 3 stock splits, with the recent split occurring on Sep 02, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

ELAB Chart

Similar

Cytosorbents Corporation
$ 0.72
-0.89%
Kalaris Therapeutics, Inc.
$ 9.81
+4.14%
CUE
Cue Biopharma Inc.
$ 0.53
-3.74%
Spectral AI Inc.
$ 1.68
+1.82%
IceCure Medical Ltd.
$ 0.68
-0.29%

PMGC Holdings Inc. (ELAB) FAQ

What is the stock price today?

The current price is $4.94.

On which exchange is it traded?

PMGC Holdings Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is ELAB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 2.24M.

Has PMGC Holdings Inc. ever had a stock split?

PMGC Holdings Inc. had 3 splits and the recent split was on Sep 02, 2025.

PMGC Holdings Inc. Profile

Biotechnology Industry
Healthcare Sector
Graydon Bensler CEO
NASDAQ (CM) Exchange
73017P300 CUSIP
US Country
2 Employees
- Last Dividend
2 Sep 2025 Last Split
- IPO Date

Overview

Elevai Labs Inc. is a prominent skincare development company that focuses on the design, manufacture, and marketing of advanced skincare products within the United States. Initially established as Reactive Medical Labs Inc., the company underwent a rebranding to Elevai Labs, Inc. in December 2021, a strategic move to better align with its mission and the innovative nature of its offerings. Since its inception in 2020, Elevai Labs has been headquartered in Newport Beach, California, from where it orchestrates its operations with an aim to serve a specific segment of the skincare market. This includes dermatologists, plastic surgeons, medical spa owners, and physicians who specialize in aesthetic and therapeutic skincare solutions. Through its dedication to innovation and quality, Elevai Labs Inc. has positioned itself as a trusted partner for professionals seeking effective post-skincare procedure care serums.

Products and Services

  • Empower Post-Skincare Procedure Care Serum:
  • This serum is meticulously designed for the face, neck, and upper chest regions, providing targeted care and recovery support following skincare procedures. Empower serum is acclaimed for its potent formula that aids in enhancing the skin's natural healing processes, thereby ensuring optimal results post-procedure.

  • Enfinity Post-Skincare Procedure Care Serum:
  • Similar to the Empower serum, Enfinity is also crafted for application on the face, neck, and upper chest areas. It is specially formulated to complement the recovery phase of skin following various aesthetic interventions. Enfinity serum stands out for its innovative ingredients that work to restore, rejuvenate, and maintain the skin’s health and appearance, post-procedure.

Contact Information

Address: 120 Newport Center Drive
Phone: 866-445-4886